MOMI-Vax study evaluates COVID-19 vaccination during pregnancy and postpartum
Tags » Emory University is participating in a study evaluating immune responses to COVID-19 vaccines, when the vaccines are administered during pregnancy or within two months after delivery. The study, called SARS-CoV-2 Vaccines in Pregnancy and Postpartum or MOMI-Vax, is sponsored and funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. MOMI-Vax is being conducted by the NIAID-funded Infectious Diseases Clinical Research Consortium (IDCRC). MOMI-Vax is open to people who have received any of the FDA-authorized COVID-19 va...